As an important step toward free access and, thus, impact of GoldenRice, a freedom-to-operate situation has been achieved for developing countries for the technology involved. Specifically, to carry the invention beyond its initial "proof-ofconcept" status in a Japonica rice (Oryza sativa) cultivar, we report here on two transformed elite Indica varieties (IR64 and MTL250) plus one Japonica variety Taipei 309. Indica varieties are predominantly consumed in the areas with vitamin A deficiency. To conform with regulatory constraints, we changed the vector backbone, investigated the absence of beyondborder transfer, and relied on Agrobacterium tumefaciens-mediated transformation to obtain defined integration patterns. To avoid an antibiotic selection system, we now rely exclusively on phosphomannose isomerase as the selectable marker. Single integrations were given a preference to minimize potential epigenetic effects in subsequent generations. These novel lines, now in the T 3 generation, are highly valuable because they are expected to more readily receive approval for follow-up studies such as nutritional and risk assessments and for breeding approaches leading to locally adapted variety development.We reported previously on a genetically modified rice line, frequently termed GoldenRice, engineered to synthesize and accumulate pro-vitamin A (-carotene) in the endosperm (Ye et al., 2000). Since then, the concept of genetic engineering-based nutritional enhancement of rice to contribute to a sustained reduction of vitamin A deficiency (VAD) has evoked strong expectations to develop in the public sector and to deliver a safe product in a short period of time. However, to carry the project from the scientific discovery to impact, i.e. to actually provide grain to subsistence farmers and urban poor in developing countries free of charge for the technology used, a large number of obstacles, not only scientific in nature, need to be dealt with. These are contractual and regulatory aspects.Contractual issues have largely been solved to date, including a "freedom-to-operate" intellectual property situation for GoldenRice, the inventors, and their licensees. Free licenses have been granted by our license collaborators for patents used in this research designed to benefit resource-poor farmers in developing countries. The next step to be taken is to find regulatory acceptance in these countries, the prerequisite for most of the tasks ahead such as to allow grain production enabling feeding trials and to begin with diversified variety development.GoldenRice as published (Ye et al., 2000) demonstrates the feasibility of the scientific approach but does not yet represent a product. Its development was based on the finding that the precursor geranylgeranyldiphosphate, which wild-type rice endosperm is capable of synthesizing, can be used by the subsequent enzyme phytoene synthase (PSY) when the latter is supplemented by transformation (Burkhardt et al., 1997). Providing the full supplement of all necessary biosynthetic genes ...